Introduction
Inflammation is a usual stimuli to injury and includes the response of the immune system in neutralizing the invading microorganisms, repair of the damaged tissues thereby promoting wound healing. [1] Inflammation process though a self-limiting process, it can become chronic and can further lead to several other serious inflammatory diseases. [2, 3] The chronic inflammations may lead to various diseases such as cancer [4] , atherosclerosis [5] , Alzheimer's [6] and rheumatoid arthritis. [7] Historically, Willow bark extracts were used to treat the fever, inflammation and pain, thereafter the non-steroidal anti-inflammatory drugs (NSAIDs) which include organic acids and non-acidic compounds and coxibs (celecoxib, rofecoxib, etc) were drugs of choice to treat inflammation. [7, 8] In contrast, these synthetic drugs were noticed to have adverse effects on cardiac, gastrointestinal, renal, and vascular functions. [8] Therefore, keeping in mind of the aforementioned drawbacks, the evolution of novel anti-inflammatory agents having lesser adverse effects are highly desirable. In this context, the screening of anti-inflammatory activity of natural product extracts (or) natural product like is an upcoming topic of research owing to lesser side effects. [9, 10] With this in mind, our attention was drawn towards "Lichens -mutualistic existence of algae and fungi". Lichen and their secondary metabolites exert a diverse range of pharmacological actions including analgesic, antibiotic, anti-inflammatory, antimycotic, antipyretic, antiviral and cytotoxic effects. [11] Dirinaria consimilis (Stirton) D.D. Awasthi is a foliose lichen belongs to the Dirinaria genus which possesses anticaries, antioxidant, antimicrobial, cytotoxic and larvicidal activities. [12] [13] [14] [15] However, there are no pharmacological study reports revealing antiinflammatory potentiality of D. consimilis and also keeping in mind of the aforementioned the biological profile of Dirinaria genus and the drawbacks of anti-inflammatory therapeutics, we anticipated Dirinaria consimilis might be active good source for anti-inflammatory activity.
Material and methods
The present study was undertaken in the Pharmaceutical Chemistry Department, AU College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India, during the period of 2016-2017.
Collection
The specimens of mangrove lichen, Dirinaria consimilis (Stirton) D. D. Awasthi was collected on the bark of mangrove plant, Excoecaria agallocha from Vainateya Island, Godavari estuary, Andhra Pradesh, India (16°44'48"N and 81°98'19"E with 0 m elevation) in February, 2015. This species were authenticated by Dr. D. K. Upreti, CSIR-National Botanical Research Institute (NBRI), Lucknow and deposited at Lichen herbarium, CSIR-NBRI, Lucknow, India with accession numbers 15-027173.
Extraction
The lichen specimens were gently collected from the barks of mangrove plant and shade dried. The dried lichen materials (150 g) were powdered, suspended in ethanolwater (1:1) for a week and evaporated under reduced pressure to obtain hydroalcoholic extracts from D. consimilis (Dc-HA, 10.91 g). The Dc-HA were re-extracted with solvents of increasing polarity, concentrated to obtain dry extracts of acetone for three times, dried over anhydrous sodium sulphate and concentrated to obtain dry of D. consimilis i.e., n-hexane (DH, 500 mg), chloroform (DC, 540 mg), ethyl acetate (DE, 602 mg), acetone (DA, 444 mg) and methanol (DM, 780 mg), which were preserved at 4°C earlier to use.
In vitro anti-inflammatory assay
Protein denaturation method [16] was employed for the evaluation of in vitro anti-inflammatory activity for D. consimilis extracts in three sets and the Mean±SD values are reported. Bovine serum albumin protein was used in this study. Study Design -The protein was solubilized to 1% concentration using sodium phosphate buffer (50 mM, pH 6.4). To 0. 
Acute Toxicity studies
The acute toxicity studies of the Dc-HA were performed by Oral Acute Toxic Class method [17] and as per OECD guidelines for their LD 50 in male rats. In this evaluation, two groups of male albino rats (n=6) administered intraperitoneally with at 1000 and 2000 mg/Kg body weight (b.w) and all the animals were retained under examination for 24 h. During this duration biological and physiological changes like aggressiveness, respiratory movements, mortality, skin changes etc., were noted.
In vivo assay
The in vivo anti-inflammatory activity was performed by formalin-induced hind rat paw oedema assay by using plethysmographic measurement of rat paw oedema caused by sub-plantar administration of 1%w/v formalin in the hind rat paw [18, 19] . The healthy albino rats of both sex were categorized into batches containing six albino rats (n=6) each. First batch served as control (administered only with 0.5% carboxymethyl cellulose), second for standard drug, indomethacin (100 mg/Kg b.w) and the remaining batches served for test extracts. In order to attain accurate measurement of the paw oedema, spotting was done at just behind the tibiotorsal junction on both the hind rat paws, so that to ensure constant paw volume the paw was inserted in mercury column up to fixed mark. Inclusion criteria -All the test samples (100, 200 mg/Kg b.w) were deliquesced in 0.5% carboxymethyl cellulose and administered intraperitoneally. Immediately 30 min after sample dosage, 0.1 mL of 1% w/v formalin was administered in the plantar region of the rat left paw. The non-inflammated right paw is assisted as a reference standard. Exclusion criteria -The rat paw volume of all tested animals were measured at 2, 4 and 6 h after the sample dosage. Hence, the percentage of variation in rat paw oedema was measured and compared with that of the standard tested drugs at respective intervals of time i.e., 2, 4 and 6 h. The percentage reduction of rat paw oedema at mentioned intervals of time in the treated rats were measured by using below equation. Percentage inhibition = (C -T)/C x 100 C = volume of paw rat oedema in control animals T = volume of paw rat oedema in treated animals
Statistical analysis
The results are mentioned as Mean±SEM values of six independent experiments. Statistical significance (AP<0.05) value between the batches was measured by one-way analysis of variance (ANOVA) followed by Dunnett's test.
Results

In vitro anti-inflammatory studies
The denaturation of biological proteins causes inflammation. The denaturation pathways can be by acidic (or) alkaline reactions, heat treatment, radiation reactions, etc. Proteins lose their complex tertiary structure because of the externally induced stress under the above mentioned conditions thus leading to denaturation. The in vitro antiinflammatory capability of D. consimilis extracts (DH, DC, DE, DA and DM) were initially subjected to protein denaturation method [16] using different concentration (0.1-1 mg/mL) for extracts as well as standard (indomethacin) and data is tabulated in Table 1 . The data evident that the DC and DA revealed prominent anti-inflammatory profile, besides, DH, DE and DM depicted moderate anti-inflammatory activity ( Table 1) . The DA and DC (1 mg/mL) showed good inhibitory activity against protein denaturation with 80.08±2.61 and 71.04±1.77%, respectively, while standard drug (Indo, 1 mg/mL) with 93.71±1.29% (Table 1) . Similarly, the percentage inhibition of bovine albumin protein denaturation for DH, DE and DM were noticed to be 21.04±0.73, 23.50±0.99 and 14.22±0.79%, respectively ( Table 1) . As shown in illustrated in Figure 1 , the IC 50 values for DC and DA were 0.706 and 0.468 mg/mL, respectively, with respect to standard (Indo, 0.120 mg/mL), whereas DH, DE and DM did not show better inhibition of albumin protein up to 1 mg/mL concentration. Acute toxicity studies By following the Oral Acute Toxic Class method, Dc-HA were evaluated for median lethal dose (LD 50 ) value in male albino rats using standard protocol. The Dc-HA showed no clinical signs in the albino rats as evidenced by the LD 50 value of above 2 g/Kg b.w. From the observations, the dosage was deliberated by Smith method and found to be 100 and 200 mg/Kg b.w.
In vivo assay
The extracts of Dirinaria consimilis are active against in vitro denaturation of protein, we extended the study to evaluate them for in vivo anti-inflammatory activity by using formalin-induced rat paw oedema assay by plethesmography. [18, 19] The results are represented as the percentage reduction of oedema measured to basal paw volume. Considering the in vitro anti-inflammatory analysis and acute toxicity studies, the extracts at 100 and 200 mg/Kg b.w were subjected to standard in vivo protocol (formalininduced rat paw oedema assay by plethesmography) of antiinflammatory activity against standard drug (Indo, 100 mg/Kg b.w). It is evident for the data that the all the extracts depicted dose dependent reduction of paw oedema in formalin-induced rats. The animals administered with lower dose of DA (100 mg/Kg b.w) depicted 30.30±0.88, 33.83±1.16 and 32.09±0.90% reduction of their paw oedema at 2, 4 and 6 h, respectively, while more pronounced effect of 40.60±1.21, 56.43±0.75 and 45.10±0.82%, respectively, depletion of paw oedema was observed in rats treated with higher dose of DA (200 mg/Kg b.w), which was almost nearer to that of the standard drug (Indo, 100 mg/Kg b.w) ( Table 2 ). The DC showed moderate percentage reduction of paw oedema at 2, 4 and 6 h, whereas the DH, DE and DM revealed mild antiinflammatory activity at tested doses during the noted hours ( Table 2) . (Table 2) . From the outcomes it can be deduce that the acetone and chloroform extracts of Dirinaria consimilis are highly effective in reducing paw oedema in rats as that of the standard drugs.
Discussion
Inflammation is immensely complex and captivating. It is an elementary way in which the living tissue retaliates to injury, infection or irritation by engendering the cardinal signs i.e., calor, dolor, function laesa, rubor and tumor [1] . Basically inflammation is categorized into two formsacute (rapid stimuli to injury by furnishing plasma proteins and leukocytes to the active site of injury) and chronic inflammation (perpetuated period of inflammation) [5, 6] . Generally, acute inflammation leads to appendicitis, bronchitis, dermatitis, meningitis, sinusitis, sore throat and tonsillitis, while chronic inflammation causes aging, Alzheimer's, asthma, atherosclerosis, cancer, Crohn's disease, hepatitis, peptic ulcer, periodontitis, psoriasis, rheumatoid arthritis, sclerosis, sepsis and tuberculosis diseases [4] . On the other hand, naturally occurring antiinflammatory extracts or metabolites are preferred due to lesser side effects. In this context, lichen extracts and metabolites are chosen due to their strong pharmacological reports against inflammation [11, 12] . In the present study, preliminary screening for antiinflammatory activity was performed with protein denaturation method using bovine serum albumin protein. The tested extracts produced mild to significant inhibitory profile towards protein denaturation. Among all the tested extracts, the DA and DC depicted prominent in vitro antiinflammatory activity, which were nearer to that of the standard (indomethacin) (Figure 1 ). Considering the in vitro anti-inflammatory profile, we have initially screened for acute toxicity studies using male albino rats and found that the D. consimilis was non-toxic up to 2 g/Kg b.w. Based on the in vitro assay and oral acute toxic class method, the in vivo anti-inflammatory screening was evaluated in albino rats using formalin induced hind rat paw oedema assay at low and high doses. At both the dosage, the DA and DC showed potent inhibitory profile against rat paw oedema. Moreover, both the bioassays outcomes are almost similar and consistent. 
Conclusion
This is a preliminary report of pharmacological profile of lichen, Dirinaria consimilis. The anti-inflammatory activity was assessed by two experimental models. In protein denaturation method (in vitro), the DA depicted prominent protein inhibitory profile with IC 50 values of 468 µg/mL. In formalin induced hind rat paw oedema assay (in vivo), the DA (at both doses) revealed good inhibitory profile against rat paw oedema, demonstrative of both acute and chronic inflammation. Hence, both the bioassays depicted that the lichen, D. consimilis has good inhibitory profile against inflammation. Hence, it can be concluded that the D. consimilis have an aptitude to reduce rat paw oedema as well as inhibit protein denaturation 
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